AMRX FY 2016 Earnings — Amneal Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

AMRXAmneal Pharmaceuticals, Inc.

$4B

FY 2016 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$1.0B+17.5% YoY

Gross Profit

$597M58.7% margin

Operating Income

$285M28.0% margin

Net Income

$207M20.4% margin

EPS (Diluted)

$1.10

Cash Flow

Operating Cash Flow

$115M

Free Cash Flow

-$10M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$1.2B

Total Liabilities

$1.4B

Stockholders' Equity

-$185M

Cash & Equivalents

$27M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.0B	$866M	+17.5%
Gross Profit	$597M	$499M	+19.7%
Operating Income	$285M	$227M	+25.4%
Net Income	$207M	$169M	+22.4%